ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CERE Cerevel Therapeutics Holdings Inc

42.635
-0.075 (-0.18%)
Last Updated: 11:12:24
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cerevel Therapeutics Holdings Inc CERE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.075 -0.18% 42.635 11:12:24
Open Price Low Price High Price Close Price Previous Close
42.73 42.60 42.86 42.71
more quote information »

Recent News

Date Time Source Heading
4/18/202405:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
2/27/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/16/202415:46EDGAR2Form 8-K - Current report
2/09/202408:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2/08/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202407:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
1/23/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202406:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
1/18/202406:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
1/05/202416:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
1/02/202417:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
12/28/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/28/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202316:03EDGAR2Form 144 - Report of proposed sale of securities
12/21/202319:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202319:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202319:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202317:34EDGAR2Form 144 - Report of proposed sale of securities
12/11/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
12/08/202305:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
12/07/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:32EDGAR2Form 144 - Report of proposed sale of securities
12/07/202315:31EDGAR2Form 144 - Report of proposed sale of securities
12/07/202307:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/07/202307:00EDGAR2Form 8-K - Current report
12/07/202305:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
12/06/202322:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
12/06/202315:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
12/05/202317:42EDGAR2Form 144 - Report of proposed sale of securities
11/29/202305:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
11/08/202305:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
11/01/202305:39EDGAR2Form 8-K - Current report
11/01/202305:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
10/18/202315:32EDGAR2Form SC 13D/A - General statement of acquisition of..
10/13/202305:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
10/12/202315:19EDGAR2Form 8-K - Current report
10/12/202315:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202321:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
10/11/202315:14EDGAR2Form 8-K - Current report
10/11/202315:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202315:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

Your Recent History

Delayed Upgrade Clock